Fungal Genomics in Respiratory Medicine: What, How and When?

Respiratory infections caused by fungal pathogens present a growing global health concern and are a major cause of death in immunocompromised patients. Worryingly, coronavirus disease-19 (COVID-19) resulting in acute respiratory distress syndrome has been shown to predispose some patients to airborn...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Mycopathologia (1975) 2021-10, Vol.186 (5), p.589-608
Hauptverfasser:	Brackin, Amelie P., Hemmings, Sam J., Fisher, Matthew C., Rhodes, Johanna
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute respiratory distress syndrome Antifungal agents Aspergillosis Aspergillus fumigatus Biomedical and Life Sciences Caspofungin Coronaviruses COVID-19 Diagnosis Diseases Drug resistance in microorganisms Drug therapy Eukaryotic Microbiology Genomics Health aspects Humans Immunocompromised hosts Infections Life Sciences Medical Microbiology Microbial Ecology Microbiology Mortality Mucormycosis Pathogens Patients Plant Sciences Public health Pulmonary Medicine Respiratory agents Respiratory distress syndrome Review SARS-CoV-2 Triazoles
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!